Alatrofloxacin

Alatrofloxacin (Trovan IV) is a fluoroquinolone antibiotic developed by Pfizer, delivered as a mesylate salt.[1]

Alatrofloxacin
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
MedlinePlusa605016
Pregnancy
category
  • US: C (Risk not ruled out)
    Routes of
    administration
    Intravenous
    ATC code
    • none
    Legal status
    Legal status
    • Withdrawn
    Pharmacokinetic data
    BioavailabilityN/A
    Protein binding76% (trovafloxacin)
    MetabolismQuickly hydrolyzed to trovafloxacin
    Elimination half-life9 to 12 hours (trovafloxacin)
    ExcretionFecal and renal (trovafloxacin)
    Identifiers
    CAS Number
    ChemSpider
    UNII
    ChEMBL
    Chemical and physical data
    FormulaC26H25F3N6O5
    Molar mass558.518 g·mol−1
    3D model (JSmol)
     NY (what is this?)  (verify)

    Trovafloxacin and alatrofloxacin were both withdrawn from the U.S. market in June 2006.

    See also

    References


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.